INTERNATIONAL PATENT: THERAKIND LIMITED FILES APPLICATION FOR "ANTIMICROBIAL USE OF PEPTIDES DERIVED FROM ANNEXIN A1"

GENEVA, April 28 -- THERAKIND LIMITED (3rd Floor, 314 Regents Park RoadLondon N3 2JX) filed a patent application (PCT/GB2024/052642) for "ANTIMICROBIAL USE OF PEPTIDES DERIVED FROM ANNEXIN A1" on Oct 15, 2024. With publication no. WO/2025/083393, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUNNO, Smitta (Therakind Limited3rd Floor, 314 Regents Park RoadLondon N3 2JX), WILSON, Maria (3rd Floor, 314 Regents Park RoadLondon N3 2JX)

Abstract: There is described an Annexin A1 fragment, and variants thereof, for use in t...